PIERIS PHARMACEUTICALS GMBH - Germany 

Ranking results:

Past rankings:

Ranking timeline:

Project Participation Performance(2010-01-01 - 2024-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 1
As coordinator: 1
As participant: 0
Sole participant: 0
Coordinator / Participant Ratio: *

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2011 5.996.304 0 2.164.000 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
ANTITOPE LIMITED1
CONSULTECH TECHNOLOGIEBERATUNG1
CORIOLIS PHARMA RESEARCH1
CORIOLIS PHARMASERVICE1
COVANCE LABORATORIES1
FGK CLINICAL RESEARCH1
FUJIFILM DIOSYNTH BIOTECHNOLOGIES UK LIMITED1
MEDIZINISCHE UNIVERSITAT INNSBRUCK1
STICHTING KATHOLIEKE UNIVERSITEIT1
TECHNISCHE UNIVERSITAET MUENCHEN1

Constancy:

Total number of partners: 10
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 10
Frequent / Rare Partner Ratio: 0

Project overview:

Start dateProjectacronymrolefundingpartners
2011-08-01EUROpean consortium for antiCALINs as next generation high-affinity protein therapeutics EUROCALINcoordinator5.996.30411